dr. reckamp discusses heat shock proteins in lung cancer
Published 12 years ago • 1.7K plays • Length 1:10Download video MP4
Download video MP3
Similar videos
-
0:41
dr. reckamp describes the use of heat shock proteins
-
0:32
dr. reckamp discusses the use of hsp90 inhibitors
-
0:49
dr. reckamp on molecular testing in lung cancer
-
2:24
dr. reckamp on met-targeting strategies in nsclc
-
0:37
dr. reckamp on current heat shock protein clinical trials
-
53:42
cardiovascular health after cancer treatment
-
11:12
aging and activating the heat shock response.
-
4:17
how does lung cancer affect the body?
-
1:02
dr. reckamp on mk-2206 for the treatment of egfr wild-type nsclc
-
1:02
dr reckamp on amivantamab in egfr exon 20–mutated nsclc
-
0:59
dr. karen reckamp evaluates the predictive efficacy of the veristrat in nsclc
-
1:11
dr. reckamp on targeted therapy options for rare mutations in nsclc
-
1:06
dr. suresh ramalingam on hsp90 inhibition with ganetespib in lung cancer
-
2:00
dr. ramalingam discusses hsp90 as treatment for lung cancer
-
11:35
dr. reckamp on navigating challenges posed by covid-19
-
2:45
reckamp the role of angiogenesis in previously treated nsclc
-
1:36
dr. reckamp on cabozantinib plus erlotinib for advanced egfr-mutant nsclc
-
6:10
can a "heat shock protein inhibitor" in standard chemo improve outcomes in advanced nsclc?
-
1:10
gracecastuc-070_lung_dr. reckamp on "which patients do you test for molecular marker, and for what?"
-
1:31
dr. bendell on hsp90 inhibition in advanced solid tumors
-
1:23
dr. suresh ramalingam explores cytotoxics in lung cancer
-
0:54
dr. li discusses the eml4-alk fusion gene